InsidersTradesSigma
Explore the detailed record of transactions filed by Taylor Michael Douglas, Director. Officer active across 1 companies, notably Deciphera Pharmaceuticals, Inc.. In total, 2 reports have been recorded. The latest transaction was filed on 3 May 2021 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations
Michael Douglas Taylor is a Director at Deciphera Pharmaceuticals, Inc. As a board member, he participates in strategic decision-making and governance of the company. His experience in the pharmaceutical sector provides valuable insights to the board.